Search
Search Results
##search.searchResults.foundPlural##
-
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1268PDF: 484HTML: 137 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2374PDF: 997HTML: 1647Fig 1: 185Tab I: 210Cover Letter: 205 -
Pseudo-differentiation syndrome
1346PDF: 659HTML: 10846Figure 1: peripheral blood showing myeloblasts with auer rods: 117Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 105Figure 3: CXR showing pulmonary infiltartes with consolidation: 136Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 109Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2098PDF: 991HTML: 4070Cover Letter: 221Figure 1: 233Figure 2: 230Table 1: 204 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4102PDF: 1587HTML: 952 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
733PDF: 846PDF Supp. Files: 78HTML: 189 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2016PDF: 758HTML: 3113 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1573PDF: 604HTML: 190 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1389PDF: 813HTML: 8660Fig 3 Savini: 171Fig 2 Savini: 178Fig 1 Savini Chest TC: 185Author letter to referees: 185 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1220PDF: 589HTML: 2860ATRA induced Reactive Hemophagocytosis: A Case Report: 197 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4798PDF: 1787HTML: 2705Untitled: 215 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
970PDF: 533HTML: 722 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4811PDF: 1800HTML: 2134 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1242PDF: 985HTML: 211 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4042PDF: 1151HTML: 1935Fig.1: 219Fig. 2: 111Table 1: 201Table2: 219Table 3: 199 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1758PDF: 877HTML: 374Fig1: 231Fig.2: 251Fig. 3: 181Fig. 5: 195Fig. 4: 223 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4088PDF: 1240HTML: 1955Table 1: 195 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1526PDF: 941HTML: 222 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1297PDF: 1008HTML: 122 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
872PDF: 475HTML: 125Suppl. Files: 312 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1046PDF: 1224Suppl. Files: 146HTML: 69







